Header Logo

Connection

Madhuri Wadehra to Biomarkers, Tumor

This is a "connection" page, showing publications Madhuri Wadehra has written about Biomarkers, Tumor.
Connection Strength

1.979
  1. ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas. Sci Rep. 2021 06 07; 11(1):11949.
    View in: PubMed
    Score: 0.720
  2. EMP2 Is a Novel Regulator of Stemness in Breast Cancer Cells. Mol Cancer Ther. 2020 08; 19(8):1682-1695.
    View in: PubMed
    Score: 0.670
  3. Understanding the Role of Endothelial Cells in Glioblastoma: Mechanisms and Novel Treatments. Int J Mol Sci. 2024 Jun 01; 25(11).
    View in: PubMed
    Score: 0.221
  4. Tissue microarray analysis for epithelial membrane protein-2 as a novel biomarker for gliomas. Brain Tumor Pathol. 2018 Jan; 35(1):1-9.
    View in: PubMed
    Score: 0.139
  5. EMP2 is a novel therapeutic target for endometrial cancer stem cells. Oncogene. 2017 10 19; 36(42):5793-5807.
    View in: PubMed
    Score: 0.137
  6. HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma. Hepatology. 2023 03 01; 77(3):774-788.
    View in: PubMed
    Score: 0.051
  7. Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma. J Neurooncol. 2020 Mar; 147(1):15-24.
    View in: PubMed
    Score: 0.041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.